Format

Send to

Choose Destination
Zhongguo Zhong Yao Za Zhi. 2007 Sep;32(17):1800-3.

[Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment].

[Article in Chinese]

Author information

1
Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China.

Abstract

OBJECTIVE:

To evaluate the effectiveness of Shenwu gelatin capsule (compound Chinese ginseng and fleeceflower root etc) in the treatment on senile mild cognitive impairment.

METHOD:

166 patients meeting criteria for mild cognitive impairment were selected from patients in Dongzhimen Hospital and were randomly assigned into a treatment group (n = 83 cases), given 5 capsules of Shenwu gelatin capsule, and a positive control group (n = 83 cases) , given 2 capsules of aniracetam with 3 placebo capsules. All subjects took this medication 3 times a day for 3 months, double-blind and double-moulding control were used in this study. At a baseline and end (three months later), all subjects were assessed using a battery consisting of MMSE and clinical memory scale (CMS).

RESULT:

Both Shenwu gelatin capsule and aniracetam can remarkably increase the score of memory quotient (MQ), P < 0. 01. They have the similarly effectiveness, there are no statistical difference between the two groups in effectiveness of increasing memory scores.

CONCLUSION:

Shenwu gelatin capsule has certain effects on mild cognitive impairment.

PMID:
17993008
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center